急性心不全における胸腔形成のランダム化制御試験
Signe Glargaard1, Jakob Hartvig Thomsen1,2, Christian Tuxen1
1Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Denmark (S.G., J.H.T., C.T., J.J.T.).
Circulation
|April 1, 2025
まとめ
急性心不全および胞流出の患者では,前部胸腔移植による結果が改善されなかった. TAP- IT試験では,標準的な治療のみと比較して,病院の外での生存日数や死亡率が有意な違いを示さなかった.
科学分野:
- 心臓病科
- 肺科
- 介入心臓科
背景:
- 急性心不全はしばしば胞流出で示され,患者の予後に影響を与えます.
- 治療的胸腔切開は,これらの流出を管理するための潜在的な介入です.
研究 の 目的:
- 急性心不全の患者において,標準的な治療と併用した前方胸腔移植の有効性を評価する.
- 標準治療のみと比較して,この戦略が重要な臨床結果を改善するかどうかを判断する.
主な方法:
- 135人の急性心不全患者と胸腔出血を対象とした多センターランダム化対照試験 (TAP- IT)
- 患者はランダムに超音波誘導胸腔切開と標準治療,または標準治療のみに割り当てられました.
- 主なアウトカムには,入院期間と死亡率が含まれていた.
主要な成果:
- 胸腔移植と対照群の生存期間90日間の有意な差は認められなかった (中位84日対82日,P=0. 42).
- 両群とも90日間の全因死亡率が13%で,生存確率の違いはなかった (P=0. 90).
- インデックス入院時間の有意な差は認められなかった.
結論:
- 標準的な治療に加え,急性心不全および胞流出の患者では,90日間のアウトカムが改善されなかった.
- 研究結果は,この患者集団において,定期的な胸腔切開が有益でないことを示唆している.
- これらの結果を確認し,最適な管理戦略を探るため,さらなる研究が必要である.
さらに関連する動画
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
13.2K
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.6K
関連する概念動画
Endoscopic Studies II: Thoracocentesis
178
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
178
Pneumothorax-II
110
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
110
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Pneumothorax-I
161
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
161
Flail Chest-II
148
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
148
